Trials / Completed
CompletedNCT02166268
Evaluation of the Efficacy and Safety of AVANZ® Phleum Pratense in Grass Pollen-induced Allergic Rhinitis During Controlled Exposure in an Environmental Challenge Chamber
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 140 (actual)
- Sponsor
- ALK-Abelló A/S · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The clinical trial will investigate the efficacy of Avanz Phleum pratense in the treatment of rhinitis in an environmental challenge chamber.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AVANZ Phleum pratense 15,000 SQ+ | |
| DRUG | Placebo |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-10-01
- Completion
- 2015-10-01
- First posted
- 2014-06-18
- Last updated
- 2016-01-26
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02166268. Inclusion in this directory is not an endorsement.